[Congressional Record Volume 168, Number 198 (Tuesday, December 20, 2022)]
[Senate]
[Pages S9613-S9614]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




    CHILDHOOD CANCER SURVIVORSHIP, TREATMENT, ACCESS, AND RESEARCH 
                      REAUTHORIZATION ACT OF 2022

  Mr. HEINRICH. Mr. President, I ask unanimous consent that the 
Committee on Health, Education, Labor, and Pensions be discharged from 
further consideration of S. 4120 and the Senate proceed to its 
immediate consideration.
  The PRESIDING OFFICER. The clerk will report the bill by title.
  The senior assistant legislative clerk read as follows:

       A bill (S. 4120) to maximize discovery, and accelerate 
     development and availability, of promising childhood cancer 
     treatments, and for other purposes.

  There being no objection, the committee was discharged, and the 
Senate proceeded to consider the bill.
  Mr. HEINRICH. I ask unanimous consent that the Reed substitute 
amendment at the desk be considered and agreed to; that the bill, as 
amended, be considered read a third time and passed; and that the 
motion to reconsider be considered made and laid upon the be table.
  The PRESIDING OFFICER. Without objection, it is so ordered.
  The amendment (No. 6584) in the nature of a substitute was agreed to, 
as follows:

                (Purpose: In the nature of a substitute)

        Strike all after the enacting clause and insert the 
     following:

     SECTION 1. SHORT TITLE.

       This Act may be cited as the ``Childhood Cancer 
     Survivorship, Treatment, Access, and Research Reauthorization 
     Act of 2022'' or the ``Childhood Cancer STAR Reauthorization 
     Act''.

     SEC. 2. REAUTHORIZING AND IMPROVING THE CHILDHOOD STAR ACT.

       (a) Children's Cancer Biorepositories.--Section 417E of the 
     Public Health Service Act (42 U.S.C. 285a-11) is amended--
       (1) in subsection (a)--
       (A) in paragraph (2)(A), by inserting before the period at 
     the end of the second sentence the following: ``, such as 
     collected samples of both solid tumor cancer and paired 
     samples'';
       (B) in paragraph (9), by striking ``Childhood Cancer 
     Survivorship, Treatment, Access, and Research Act of 2018'' 
     and inserting ``Childhood Cancer Survivorship, Treatment, 
     Access, and Research Reauthorization Act of 2022'';
       (C) by redesignating paragraph (10) as paragraph (11); and
       (D) by inserting after paragraph (9) the following:
       ``(10) Report on researcher access to children's cancer 
     biorepository samples.--Not later than 2 years after the date 
     of enactment of the Childhood Cancer Survivorship, Treatment, 
     Access, and Research Reauthorization Act of 2022, the 
     Director of NIH shall--
       ``(A) conduct a review of the procedures established under 
     paragraph (2)(C) and other policies or procedures related to 
     researcher access to such biospecimens to identify any 
     opportunities to reduce administrative burden, consistent 
     with paragraph (2)(D), in a manner that protects personal 
     privacy to the extent required by applicable Federal and 
     State privacy law, at a minimum; and
       ``(B) submit to the Committee on Health, Education, Labor, 
     and Pensions of the Senate and the Committee on Energy and 
     Commerce of the House of Representatives a report on the 
     findings of the review under subparagraph (A) and whether the 
     Director of NIH plans to make any changes to the policies or 
     procedures considered in such review, based on such 
     findings.''; and
       (2) in subsection (d), by striking ``2019 through 2023'' 
     and inserting ``2024 through 2028''.
       (b) Cancer Survivorship Programs.--Section 201 of the 
     Childhood Cancer Survivorship, Treatment, Access, and 
     Research Act of 2018 (Public Law 115-180) is amended--
       (1) in subsection (a)--
       (A) in the subsection heading, by striking ``Pilot Programs 
     to Explore'' and inserting ``Research to Evaluate''
       (B) in paragraph (1)--
       (i) by striking ``may make awards to eligible entities to 
     establish pilot programs'' and inserting ``shall, as 
     appropriate, make awards to eligible entities to conduct or 
     support research'';
       (ii) by striking ``model systems'' and inserting 
     ``approaches'';
       (iii) by inserting ``and adolescent'' after ``childhood''; 
     and
       (iv) by striking ``evaluation of models for'';
       (C) in paragraph (2)--
       (i) in subparagraph (A), in the matter preceding clause 
     (i), by inserting ``within the

[[Page S9614]]

     existing peer review process,'' after ``practicable,''; and
       (ii) in subparagraph (B)(v), by striking ``in treating 
     survivors of childhood cancers'' and inserting ``in carrying 
     out the activities described in paragraph (1)''; and
       (D) in paragraph (3)(B)(v), by striking ``design of systems 
     for the effective transfer of treatment information and care 
     summaries from cancer care providers to other health care 
     providers'' and inserting ``design tools to support the 
     secure electronic transfer of treatment information and care 
     summaries between health care providers or, as applicable and 
     appropriate, longitudinal childhood cancer survivorship 
     cohorts''; and
       (2) in subsection (b)--
       (A) in each of paragraphs (1) and (2), by striking ``date 
     of enactment of this Act'' and inserting ``date of enactment 
     of the Childhood Cancer Survivorship, Treatment, Access, and 
     Research Reauthorization Act of 2022''; and
       (B) in paragraph (1)--
       (i) by striking subparagraphs (A) and (C);
       (ii) by redesignating subparagraph (B) as subparagraph (A); 
     and
       (iii) by adding at the end the following:
       ``(B) recommendations for enhancing or promoting activities 
     of the Department of Health and Human Services related to 
     workforce development for health care providers who provide 
     psychosocial care to pediatric cancer patients and 
     survivors.''.

  The bill (S. 4120), as amended, was ordered to be engrossed for a 
third reading, was read the third time, and passed.

                          ____________________